Aro Biotherapeutics Expands Leadership Team with Addition of Proven Scientific Executives
Published: Feb 23, 2021 PHILADELPHIA--(BUSINESS WIRE)-- Aro Biotherapeutics, a biotechnology company pioneering the development of tissue-targeted genetic medicines, today announced that Adam Dinerman, Ph.D. and John Liu, Ph.D. have joined the company as Executive Director, Head of Chemistry, Manufacturing and Controls (CMC) and Vice President, Biology, respectively. “The addition of top talent with deep functional experience is a critical success driver for Aro as we enter our next phase of growth,” stated Sue Dillon, Ph.D., co-founder and Chief Executive Officer of Aro Biother...
Source: biospace.com